APA (7th ed.) Citation

Toulmin, S. A., Bhadiadra, C., Paris, A. J., Lin, J. H., Katzen, J., Basil, M. C., . . . Eisenlohr, L. C. (2021). Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation. Nature Portfolio.

Chicago Style (17th ed.) Citation

Toulmin, Sushila A., Chaitali Bhadiadra, Andrew J. Paris, Jeffrey H. Lin, Jeremy Katzen, Maria C. Basil, Edward E. Morrisey, G. Scott Worthen, and Laurence C. Eisenlohr. Type II Alveolar Cell MHCII Improves Respiratory Viral Disease Outcomes While Exhibiting Limited Antigen Presentation. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Toulmin, Sushila A., et al. Type II Alveolar Cell MHCII Improves Respiratory Viral Disease Outcomes While Exhibiting Limited Antigen Presentation. Nature Portfolio, 2021.